Premium
Asperfuranone from Aspergillus nidulans Inhibits Proliferation of Human Non‐Small Cell Lung Cancer A549 Cells via Blocking Cell Cycle Progression and Inducing Apoptosis
Author(s) -
Wang Clay C. C.,
Chiang YiMing,
Praseuth Mike B.,
Kuo PoLin,
Liang HsinLin,
Hsu YaLing
Publication year - 2010
Publication title -
basic and clinical pharmacology and toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.805
H-Index - 90
eISSN - 1742-7843
pISSN - 1742-7835
DOI - 10.1111/j.1742-7843.2010.00545.x
Subject(s) - fas ligand , apoptosis , cell cycle , a549 cell , cell , cell growth , aspergillus nidulans , cell cycle checkpoint , ligand (biochemistry) , microbiology and biotechnology , fas receptor , cancer cell , cancer research , biology , chemistry , cancer , receptor , programmed cell death , biochemistry , gene , genetics , mutant
Asperfuranone, a novel compound of genomic mining in Aspergillus nidulans , was investigated for its anti‐proliferative activity in human non‐small cell lung cancer A549 cells. To identity the anti‐cancer mechanism of asperfuranone, we assayed its effect on apoptosis, cell cycle distribution, and levels of p53, p21 Waf1/Cip1, Fas/APO‐1 receptor and Fas ligand. Enzyme‐linked immunosorbent assay showed that the G0/G1 phase arrest might be due to p53‐dependent induction of p21 Waf1/Cip1. An enhancement in Fas/APO‐1 and its two form ligands, membrane‐bound Fas ligand (mFasL) and soluble Fas ligand (sFasL), might be responsible for the apoptotic effect induced by asperfuranone. Our study reports here for the first time that the induction of p53 and the activity of Fas/Fas ligand apoptotic system may participate in the anti‐proliferative activity of asperfuranone in A549 cells.